Technetium (99mTc) medronic acid
Radiopharmaceutical used in bone imaging
| Technetium (99mTc) medronic acid
| |
|---|---|
| Routes | Intravenous
|
Technetium (99mTc) medronic acid is a radiopharmaceutical used primarily in nuclear medicine for bone imaging. It is a compound that combines technetium-99m (99mTc), a widely used radioisotope, with medronic acid, a phosphonate compound that targets bone tissue.
Mechanism of Action[edit]
Technetium (99mTc) medronic acid works by binding to the hydroxyapatite crystals in bone. The technetium-99m emits gamma radiation, which can be detected by a gamma camera. This allows for the visualization of bone structure and the identification of abnormalities such as bone metastases, fractures, and osteomyelitis.
Clinical Use[edit]
Technetium (99mTc) medronic acid is used in bone scintigraphy, a diagnostic imaging technique. It is particularly useful for detecting bone metastases in patients with cancer, evaluating unexplained bone pain, and diagnosing osteomyelitis.
Administration[edit]
The compound is administered intravenously. After injection, it typically takes about 2-4 hours for optimal imaging, as the radiopharmaceutical accumulates in the bone tissue.
Safety and Side Effects[edit]
Technetium (99mTc) medronic acid is generally well-tolerated. However, potential side effects include allergic reactions, injection site reactions, and, rarely, radiation exposure risks. It is contraindicated in patients with known hypersensitivity to any component of the formulation.
Related Pages[edit]
Categories[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
